United States · 
Who invested in Tallac Therapeutics?
Tallac Therapeutics's investors include Matrix Partners China.
United States · Funded startup
Who invested in Tallac Therapeutics
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Debt, $5.0MAug 2023
- Investors
- 1
The rounds
- Aug 2023
Founders and team
From Tallac Therapeutics's own website and the SEC filings it signed: 8 on the team.
- Hong I.President, CEO and
- Amy ChenPrincipal Scientist
- Danielle FontaineScientific Associate II
- Emma SangalangPrincipal Scientist
- Maja BonacorsiPrincipal Scientist
- Verwina Robleboard of directors
- Hong WanExecutive Officer, Directori
- Ons HarrabiTeam
On the board, as filediChristine BrennanCorey GoodmanIsaac ChengJaume PonsMichael CarusiRan Geng
Also claim to have backed them
This firm lists Tallac Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Tallac Therapeutics
How much has Tallac Therapeutics raised?
Tallac Therapeutics has raised $5.0M across 1 round since 2023.
When did Tallac Therapeutics last raise?
Tallac Therapeutics's most recent round was a Debt of $5.0M in Aug 2023.
What was Tallac Therapeutics's biggest round?
Its most recent round, $5.0M in Aug 2023, is also its largest on record.
Who backed Tallac Therapeutics first?
Tallac Therapeutics's first round on record, in Aug 2023, was backed by Matrix Partners China.
What stage is Tallac Therapeutics at?
Tallac Therapeutics's latest named round is a Debt, in Aug 2023.
Where is Tallac Therapeutics based?
Tallac Therapeutics is based in the United States.
Companies like Tallac Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.